M Kadawathagedara1, A Chan Hon Tong2, B Heude3, A Forhan3, M-A Charles3, V Sirot2, J Botton4. 1. INSERM, Unit 1153, Research Center in Epidemiology and Biostatistics Paris Sorbonne Cité, Team: Early Origin of the Child's Health and Development, Paris Descartes 5 University, 16, Avenue Paul Vaillant-Couturier, 94807 Villejuif Cedex, France. Electronic address: manik.kadawathagedara@inserm.fr. 2. ANSES (French agency for Food, Environmental, and Occupational Health and Safety), 14 rue Pierre et Marie Curie, F-94701 Maisons-Alfort, France. 3. INSERM, Unit 1153, Research Center in Epidemiology and Biostatistics Paris Sorbonne Cité, Team: Early Origin of the Child's Health and Development, Paris Descartes 5 University, 16, Avenue Paul Vaillant-Couturier, 94807 Villejuif Cedex, France. 4. INSERM, Unit 1153, Research Center in Epidemiology and Biostatistics Paris Sorbonne Cité, Team: Early Origin of the Child's Health and Development, Paris Descartes 5 University, 16, Avenue Paul Vaillant-Couturier, 94807 Villejuif Cedex, France; Faculty of Pharmacy, University Paris Sud, Châtenay-Malabry, France.
Abstract
BACKGROUND AND AIM: Acrylamide is a contaminant formed in a wide variety of carbohydrate-containing foods during frying or baking at high temperatures. Recent studies have suggested reduced foetal growth after exposure to high levels of acrylamide during pregnancy. OBJECTIVE: To study the relationship between maternal dietary acrylamide intake during pregnancy and their offspring's anthropometry at birth. DESIGN: In our population of 1471 mother-child pairs from two French cities, Nancy and Poitiers, dietary acrylamide intake during pregnancy was assessed by combining maternal food frequency questionnaires with data on food contamination at the national level, provided by the second "French Total Diet Study". Newborns weighing less than the 10th percentile, according to a customised definition, were defined as small for gestational age (SGA). Linear and logistic regression models were used to study continuous and binary outcomes respectively, adjusting for the study centre, maternal age at delivery, height, education, parity, smoking during pregnancy, the newborn's gestational age at birth and sex. RESULTS: The median and interquartile range of dietary acrylamide intake were 19.2μg/day (IQR, 11.8;30.3). Each 10μg/day increase in acrylamide intake was associated with an odds-ratio for SGA of 1.11 (95% Confidence Interval: 1.03,1.21), birth length change of -0.05cm (95% CI: -0.11,0.00) and birth weight change of -9.8g (95% CI: -21.3,1.7). CONCLUSIONS: Our results, consistent with both experimental and epidemiological studies, add to the evidence of an effect of acrylamide exposure on the risk of SGA and suggest an effect on foetal growth, for both weight and length.
BACKGROUND AND AIM: Acrylamide is a contaminant formed in a wide variety of carbohydrate-containing foods during frying or baking at high temperatures. Recent studies have suggested reduced foetal growth after exposure to high levels of acrylamide during pregnancy. OBJECTIVE: To study the relationship between maternal dietary acrylamide intake during pregnancy and their offspring's anthropometry at birth. DESIGN: In our population of 1471 mother-child pairs from two French cities, Nancy and Poitiers, dietary acrylamide intake during pregnancy was assessed by combining maternal food frequency questionnaires with data on food contamination at the national level, provided by the second "French Total Diet Study". Newborns weighing less than the 10th percentile, according to a customised definition, were defined as small for gestational age (SGA). Linear and logistic regression models were used to study continuous and binary outcomes respectively, adjusting for the study centre, maternal age at delivery, height, education, parity, smoking during pregnancy, the newborn's gestational age at birth and sex. RESULTS: The median and interquartile range of dietary acrylamide intake were 19.2μg/day (IQR, 11.8;30.3). Each 10μg/day increase in acrylamide intake was associated with an odds-ratio for SGA of 1.11 (95% Confidence Interval: 1.03,1.21), birth length change of -0.05cm (95% CI: -0.11,0.00) and birth weight change of -9.8g (95% CI: -21.3,1.7). CONCLUSIONS: Our results, consistent with both experimental and epidemiological studies, add to the evidence of an effect of acrylamide exposure on the risk of SGA and suggest an effect on foetal growth, for both weight and length.
Authors: Lorne J Hofseth; James R Hebert; Anindya Chanda; Hexin Chen; Bryan L Love; Maria M Pena; E Angela Murphy; Mathew Sajish; Amit Sheth; Phillip J Buckhaults; Franklin G Berger Journal: Nat Rev Gastroenterol Hepatol Date: 2020-02-21 Impact factor: 46.802
Authors: Elodie Sarron; Maxime Pérot; Nicolas Barbezier; Carine Delayre-Orthez; Jérôme Gay-Quéheillard; Pauline M Anton Journal: World J Gastroenterol Date: 2020-06-21 Impact factor: 5.742
Authors: Janneke Hogervorst; Hubert W Vesper; Narjes Madhloum; Wilfried Gyselaers; Tim Nawrot Journal: Environ Health Date: 2021-04-01 Impact factor: 5.984
Authors: Clara Amalie Gade Timmermann; Signe Sonne Mølck; Manik Kadawathagedara; Anne Ahrendt Bjerregaard; Margareta Törnqvist; Anne Lise Brantsæter; Marie Pedersen Journal: Toxics Date: 2021-06-30
Authors: Hanna Mojska; Iwona Gielecińska; Edyta Jasińska-Melon; Joanna Winiarek; Włodzimierz Sawicki Journal: Int J Environ Res Public Health Date: 2020-10-11 Impact factor: 3.390